Current status of inflammasome blockers as anti-inflammatory drugs

Bibliography

• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Apetoh L, Tesniere A, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009;15:1170-8
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-50
   PubMed Web of Science ®Google Scholar
• Watkins LR, Hansen MK, Nguyen KT, Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Life Sci 1999;65:449-81
   PubMed Web of Science ®Google Scholar
• Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011;29:707-35
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007;14:10-22
   PubMed Web of Science ®Google Scholar
• Jin Y, Mailloux CM, Gowan K, NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007;356:1216-25
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009;7:99-109
   PubMed Web of Science ®Google Scholar
• Miao EA, Leaf IA, Treuting PM, Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010;11:1136-42
   PubMed Web of Science ®Google Scholar
• Meixenberger K, Pache F, Eitel J, Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol 2010;184:922-30
   PubMed Web of Science ®Google Scholar
• Perregaux D, Gabel CA. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994;269:15195-203
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Weiss DS, Newton K, Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006;440:228-32
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-26
   PubMed Web of Science ®Google Scholar
• He X, Mekasha S, Mavrogiorgos N, Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol 2010;184:5743-54
   PubMed Web of Science ®Google Scholar
• Barbera-Cremades M, Baroja-Mazo A, Gomez AI, P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. Faseb J 2012; doi: 10.1096/fj.12-205765
   PubMed Web of Science ®Google Scholar
• Weber FC, Esser PR, Muller T, Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity. J Exp Med 2010;207:2609-19
   PubMed Web of Science ®Google Scholar
• Wilhelm K, Ganesan J, Muller T, Graft-versus-host disease is enhanced by extracellular ATP activating P2X(7)R. Nat Med 2010;16:1434-8
   PubMed Web of Science ®Google Scholar
• Ferrari D, Chiozzi P, Falzoni S, Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 1997;159:1451-8
   PubMed Web of Science ®Google Scholar
• Stokes L, Jiang LH, Alcaraz L, Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br J Pharmacol 2006;149:880-7
   PubMed Web of Science ®Google Scholar
• Solle M, Labasi J, Perregaux DG, Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001;276:125-32
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Newton K, Monack DM, Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430:213-18
   PubMed Web of Science ®Google Scholar
• Walev I, Reske K, Palmer M, Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J 1995;14:1607-14
   PubMed Web of Science ®Google Scholar
• Petrilli V, Papin S, Dostert C, Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007;14:1583-9
   PubMed Web of Science ®Google Scholar
• Luheshi NM, Giles JA, Lopez-Castejon G, Sphingosine regulates the NLRP3-inflammasome and IL-1beta release from macrophages. Eur J Immunol 2011;42:716-25
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 2006;25:5071-82
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem 2007;282:2386-94
   PubMed Web of Science ®Google Scholar
• Rider T, Jordan K. The modern management of gout. Rheumatology (Oxford) 2010;49:5-14
   PubMed Web of Science ®Google Scholar
• Martinon F, Petrilli V, Mayor A, Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41
   PubMed Web of Science ®Google Scholar
• Perkins RC, Scheule RK, Hamilton R, Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp Lung Res 1993;19:55-65
   PubMed Web of Science ®Google Scholar
• Dostert C, Petrilli V, Van Bruggen R, Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-7
   PubMed Web of Science ®Google Scholar
• Hornung V, Bauernfeind F, Halle A, Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008;9:847-56
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010;11:136-40
   PubMed Web of Science ®Google Scholar
• Zhou R, Yazdi AS, Menu P, A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-5
   PubMed Web of Science ®Google Scholar
• Shimada K, Crother TR, Karlin J, Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis. Immunity 2012;36:401-14
   PubMed Web of Science ®Google Scholar
• Rubartelli A, Gattorno M, Netea MG, Interplay between redox status and inflammasome activation. Trends Immunol 2011;32:559-66
   PubMed Web of Science ®Google Scholar
• Miao EA, Warren SE. Innate immune detection of bacterial virulence factors via the NLRC4 inflammasome. J Clin Immunol 2010;30:502-6
   PubMed Web of Science ®Google Scholar
• Warren SE, Mao DP, Rodriguez AE, Multiple Nod-like receptors activate caspase 1 during listeria monocytogenes infection. J Immunol 2008;180:7558-64
   PubMed Web of Science ®Google Scholar
• Sutterwala FS, Mijares LA, Li L, Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 2007;204:3235-45
   PubMed Web of Science ®Google Scholar
• Miao EA, Mao DP, Yudkovsky N, Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. PNAS 2010;107:3076-80
   PubMed Web of Science ®Google Scholar
• Hsu LC, Ali SR, McGillivray S, A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. PNAS 2008;105:7803-8
   PubMed Web of Science ®Google Scholar
• Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006;38:240-4
   PubMed Web of Science ®Google Scholar
• Faustin B, Lartigue L, Bruey JM, Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007;25:713-24
   PubMed Web of Science ®Google Scholar
• Hornung V, Latz E. Intracellular DNA recognition. Nat Rev Immunol 2010;10:123-30
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Jiang Z, Waggoner SN, The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010;11:395-402
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Juliana C, The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010;11:385-93
   PubMed Web of Science ®Google Scholar
• Sauer JD, Witte CE, Zemansky J, Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 2010;7:412-19
   PubMed Web of Science ®Google Scholar
• Poeck H, Bscheider M, Gross O, Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 2010;11:63-9
   PubMed Web of Science ®Google Scholar
• Seshadri S, Duncan MD, Hart JM, Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1beta processing and release. J Immunol 2007;179:1274-81
   PubMed Web of Science ®Google Scholar
• Stehlik C, Dorfleutner A. COPs and POPs: modulators of inflammasome activity. J Immunol 2007;179:7993-8
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Quartier P, So A, The emerging role of interleukin-1beta in autoinflammatory diseases. Arthritis Rheum 2011;63:314-24
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Jin C, Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012;482:179-85
   PubMed Web of Science ®Google Scholar
• Hu B, Elinav E, Huber S, Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. PNAS 2010;107:21635-40
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 2010;29:317-29
   PubMed Web of Science ®Google Scholar
• Larsen CM, Faulenbach M, Vaag A, Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009;32:1663-8
   PubMed Web of Science ®Google Scholar
• Owyang AM, Maedler K, Gross L, XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model. Endocrinology 2010;151:2515-27
   PubMed Web of Science ®Google Scholar
• Masters SL, Dunne A, Subramanian SL, Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010;11:897-904
   PubMed Web of Science ®Google Scholar
• Duewell P, Kono H, Rayner KJ, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357-61
   PubMed Web of Science ®Google Scholar
• Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin Exp Immunol 2011;164(Suppl 1):20-2
   PubMed Web of Science ®Google Scholar
• Ikeda K, Yamaguchi K, Tanaka T, Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol 2010;160:246-55
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011;242:233-46
   PubMed Web of Science ®Google Scholar
• Macaluso F, Nothnagel M, Parwez Q, Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis. Exp Dermatol 2007;16:692-8
   PubMed Web of Science ®Google Scholar
• Dostert C, Petrilli V, Van Bruggen R, Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-7
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 2009;28:2114-27
   PubMed Web of Science ®Google Scholar
• Bauernfeind F, Bartok E, Rieger A, Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 2011;187:613-17
   PubMed Web of Science ®Google Scholar
• Ziment I. Acetylcysteine: a drug that is much more than a mucokinetic. Biomed Pharmacother 1988;42:513-19
   PubMed Web of Science ®Google Scholar
• Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003;31:2574-8
   PubMed Web of Science ®Google Scholar
• Prendergast BD. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents. Clin Pharm 1984;3:473-85
   PubMedGoogle Scholar
• Hamon Y, Luciani MF, Becq F, Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 1997;90:2911-15
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Mueller JL, Vitari AC, Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 2009;187:61-70
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhu AG, Mamczur M, Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids. Br J Pharmacol 2007;151:1033-40
   PubMedGoogle Scholar
• McNicholas CM, Guggino WB, Schwiebert EM, Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. PNAS 1996;93:8083-8
   PubMed Web of Science ®Google Scholar
• Dal-Secco D, Cunha TM, Freitas A, Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels. J Immunol 2008;181:4287-98
   PubMed Web of Science ®Google Scholar
• Koh GCKW, Maude RR, Schreiber MF, Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis 2011;52:717-25
   PubMed Web of Science ®Google Scholar
• Riteau N, Gasse P, Fauconnier L, Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 2010;182:774-83
   PubMed Web of Science ®Google Scholar
• Labasi JM, Petrushova N, Donovan C, Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002;168:6436-45
   PubMed Web of Science ®Google Scholar
• Keating C, Pelegrin P, Martinez CM, P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome. J Immunol 2011;187:1467-74
   PubMed Web of Science ®Google Scholar
• King BF. Novel P2X7 receptor antagonists ease the pain. Br J Pharmacol 2007;151:565-7
   PubMed Web of Science ®Google Scholar
• Pelegrin P. Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1. Drug News Perspect 2008;21:424-33
   PubMed Web of Science ®Google Scholar
• Arulkumaran N, Unwin RJ, Tam FW. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 2011;20:897-915
   PubMed Web of Science ®Google Scholar
• Honore P, Donnelly-Roberts D, Namovic M, The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice. Behav Brain Res 2009;204:77-81
   PubMed Web of Science ®Google Scholar
• Stamp LK, Jordan S. The challenges of gout management in the elderly. Drugs Aging 2011;28:591-603
   PubMed Web of Science ®Google Scholar
• Bao L, Locovei S, Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett 2004;572:65-8
   PubMed Web of Science ®Google Scholar
• Qu Y, Misaghi S, Newton K, Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J Immunol 2011;186:6553-61
   Web of Science ®Google Scholar
• Baroja-Mazo A, Barbera-Cremades M, Pelegrin P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim Biophys Acta 2012 doi:10.1016/j.bbamem.2012.01.002
   PubMed Web of Science ®Google Scholar
• Ma W, Hui H, Pelegrin P, Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther 2009;328:409-18
   PubMed Web of Science ®Google Scholar
• Silverman W, Locovei S, Dahl G. Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol 2008;295:C761-7
   PubMed Web of Science ®Google Scholar
• Molto A, Olive A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine 2010;77:102-7
   PubMed Web of Science ®Google Scholar
• Granowitz EV, Porat R, Mier JW, Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992;4:353-60
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Blocking interleukin-1beta in acute and chronic autoinflammatory diseases. J Intern Med 2010;269:16-28
   Web of Science ®Google Scholar
• Feist E, Burmester GR. Canakinumab for treatment of cryopyrin-associated periodic syndrome. Expert Opin Biol Ther 2010;10:1631-6
   PubMed Web of Science ®Google Scholar
• Owyang AM, Issafras H, Corbin J, XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1beta-mediated diseases. MAbs 2011;3:49-60
   PubMed Web of Science ®Google Scholar
• Gul A, Tugal-Tutkun I, Dinarello CA, Interleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis 2012;71:563-6
   PubMed Web of Science ®Google Scholar
• Sollberger G, Strittmatter GE, Kistowska M, Caspase-4 is required for activation of inflammasomes. J Immunol 2012;188:1992-2000
   PubMed Web of Science ®Google Scholar
• Maelfait J, Vercammen E, Janssens S, Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J Exp Med 2008;205:1967-73
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-26
   PubMed Web of Science ®Google Scholar
• Boost KA, Hoegl S, Hofstetter C, Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive Care Med 2007;33:863-71
   PubMed Web of Science ®Google Scholar
• Paszkowski AS, Rau B, Mayer JM, Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann Surg 2002;235:68-76
   PubMed Web of Science ®Google Scholar
• Siegmund B. Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation. Biochem Pharmacol 2002;64:1-8
   PubMed Web of Science ®Google Scholar
• Kast RE. Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery. JOP 2008;9:350-3
   PubMedGoogle Scholar
• Wannamaker W, Davies R, Namchuk M, (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl- butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther 2007;321:509-16
   PubMed Web of Science ®Google Scholar
• Duncan JA, Bergstralh DT, Wang Y, Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. PNAS 2007;104:8041-6
   PubMed Web of Science ®Google Scholar
• Coll RC, O'Neill LAJ. The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One 2011;6:e29539
   Google Scholar
• Laliberte RE, Perregaux DG, Hoth LR, Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J Biol Chem 2003;278:16567-78
   PubMed Web of Science ®Google Scholar
• Thacker JD, Balin BJ, Appelt DM, NLRP3 Inflammasome is a Target for Development of Broad-Spectrum Anti-Infective Drugs. Antimicrob Agents Chemother 2012;56:1921-30
   Google Scholar